Llwytho...
The benefits of statin therapy—what questions remain?
Early hydroxymethylglutaryl‐CoA reductase inhibitor (statin) trials provided the first evidence of the benefits of statin therapy in secondary prevention of coronary heart disease (CHD). Outcomes data from more recent trials involving atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastat...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Clin Cardiol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Wiley Periodicals, Inc.
2006
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654705/ https://ncbi.nlm.nih.gov/pubmed/16450792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960281103 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|